TR199801587A2 - �ns�lin �nc� molek�llerinin elde edilmesine y�nelik y�ntem. - Google Patents

�ns�lin �nc� molek�llerinin elde edilmesine y�nelik y�ntem.

Info

Publication number
TR199801587A2
TR199801587A2 TR1998/01587A TR9801587A TR199801587A2 TR 199801587 A2 TR199801587 A2 TR 199801587A2 TR 1998/01587 A TR1998/01587 A TR 1998/01587A TR 9801587 A TR9801587 A TR 9801587A TR 199801587 A2 TR199801587 A2 TR 199801587A2
Authority
TR
Turkey
Prior art keywords
insulin
obtaining
molecules
cysteinhydrochloride
cystine
Prior art date
Application number
TR1998/01587A
Other languages
English (en)
Turkish (tr)
Other versions
TR199801587A3 (tr
Inventor
Franz-Josef Rubr�Der Di.
Reinhold Keller Dr.
Original Assignee
Hoechst Marion Roussel Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Deutschland Gmbh filed Critical Hoechst Marion Roussel Deutschland Gmbh
Publication of TR199801587A3 publication Critical patent/TR199801587A3/tr
Publication of TR199801587A2 publication Critical patent/TR199801587A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TR1998/01587A 1997-08-18 1998-08-17 �ns�lin �nc� molek�llerinin elde edilmesine y�nelik y�ntem. TR199801587A2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19735711A DE19735711C2 (de) 1997-08-18 1997-08-18 Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Publications (2)

Publication Number Publication Date
TR199801587A3 TR199801587A3 (tr) 1999-03-22
TR199801587A2 true TR199801587A2 (xx) 1999-03-22

Family

ID=7839275

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01587A TR199801587A2 (xx) 1997-08-18 1998-08-17 �ns�lin �nc� molek�llerinin elde edilmesine y�nelik y�ntem.

Country Status (20)

Country Link
US (3) US5986048A (https=)
EP (2) EP0906918B1 (https=)
JP (1) JP4291900B2 (https=)
KR (2) KR100537842B1 (https=)
CN (3) CN1132845C (https=)
AR (1) AR016821A1 (https=)
AT (2) ATE217012T1 (https=)
AU (1) AU744824B2 (https=)
BR (2) BRPI9816233B8 (https=)
CA (1) CA2245151C (https=)
CZ (1) CZ295679B6 (https=)
DE (3) DE19735711C2 (https=)
DK (2) DK0980874T3 (https=)
ES (2) ES2177178T3 (https=)
HU (2) HU228161B1 (https=)
ID (1) ID20717A (https=)
PL (1) PL191901B1 (https=)
PT (2) PT980874E (https=)
RU (2) RU2205836C2 (https=)
TR (1) TR199801587A2 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
EP1242610A1 (en) * 1999-12-22 2002-09-25 Novo Nordisk A/S Method for extractive refolding of scrambledsingle-chain polypeptides
US20030212248A1 (en) * 2000-07-12 2003-11-13 Furman Thomas Charles Process to increase protein stability
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
BRPI0621124A2 (pt) 2005-12-22 2011-11-29 Genentech Inc métodos para recuperação de uma proteìna de ligação à heparina
AR062069A1 (es) * 2006-07-14 2008-10-15 Genentech Inc Replegado de proteinas recombinantes
EP2174140B1 (en) * 2007-07-03 2016-01-13 Amgen Inc. Calculation of protein concentration using inclusion body dry weight
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
MY152979A (en) 2008-01-09 2014-12-15 Sanofi Aventis Deutschland Novel insulin derivatives having an extremely delayed time-action profile
JP5677938B2 (ja) * 2008-04-30 2015-02-25 ウォックハート リサーチ センター インシュリンの再折りたたみ方法
RS59913B1 (sr) 2008-10-17 2020-03-31 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
PT3345593T (pt) 2009-11-13 2023-11-27 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
MY180661A (en) 2009-11-13 2020-12-04 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
PL2611458T3 (pl) 2010-08-30 2017-02-28 Sanofi-Aventis Deutschland Gmbh Zastosowanie AVE0010 do produkcji leku do leczenia cukrzycy typu 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
US12157766B2 (en) * 2012-08-05 2024-12-03 Absci Corporation Cytoplasmic expression system
US10421795B2 (en) 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
DK2963056T3 (da) * 2013-02-26 2020-02-17 Hanmi Pharm Ind Co Ltd Insulinanalog og anvendelse deraf
CN103694339B (zh) * 2013-12-04 2017-10-13 珠海联邦制药股份有限公司 一种甘精胰岛素前体的复性方法
WO2015138548A1 (en) 2014-03-14 2015-09-17 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
EP3229828B1 (en) 2014-12-12 2023-04-05 Sanofi-Aventis Deutschland GmbH Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
CN104911203A (zh) * 2015-06-30 2015-09-16 成都易胜科生物科技有限公司 一种重组人胰岛素的工业制备方法
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
US10689430B2 (en) 2016-05-25 2020-06-23 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
CN113773391B (zh) * 2020-06-09 2023-10-20 宁波鲲鹏生物科技有限公司 一种门冬胰岛素的制备方法
CN113773396A (zh) * 2020-06-10 2021-12-10 宁波鲲鹏生物科技有限公司 一种地特胰岛素衍生物及其应用
JP7749397B2 (ja) * 2021-09-30 2025-10-06 キヤノン株式会社 超音波ファントム及び超音波ファントムの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
GR1005153B (el) * 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
RU2045535C1 (ru) * 1991-06-18 1995-10-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ получения проинсулина человека
ATE148710T1 (de) * 1992-12-02 1997-02-15 Hoechst Ag Verfahren zur gewinnung von proinsulin mit korrekt verbundenen cystinbrücken
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
RU2081122C1 (ru) * 1994-06-16 1997-06-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ выделения и очистки инсулина или его биотехнологических предшественников
BR9408638A (pt) * 1994-12-29 2004-09-21 Bio Technology General Corp Geração de insulina humana
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Also Published As

Publication number Publication date
EP0980874A1 (de) 2000-02-23
CZ259898A3 (cs) 1999-03-17
KR20050067371A (ko) 2005-07-01
RU2302882C2 (ru) 2007-07-20
AR016821A1 (es) 2001-08-01
DE59804121D1 (de) 2002-06-20
ATE217012T1 (de) 2002-05-15
CZ295679B6 (cs) 2005-09-14
US6380355B1 (en) 2002-04-30
CN1483831A (zh) 2004-03-24
DE19735711A1 (de) 1999-02-25
ID20717A (id) 1999-02-18
KR100574580B1 (ko) 2006-04-28
BRPI9816233B1 (pt) 2016-09-27
DK0906918T3 (da) 2002-09-09
PL328108A1 (en) 1999-03-01
CN1209437A (zh) 1999-03-03
JP4291900B2 (ja) 2009-07-08
BRPI9816233B8 (pt) 2021-05-25
PL191901B1 (pl) 2006-07-31
BR9803755A (pt) 2000-03-28
AU8076398A (en) 1999-02-25
CN101186940A (zh) 2008-05-28
AU744824B2 (en) 2002-03-07
KR19990023651A (ko) 1999-03-25
PT980874E (pt) 2002-10-31
CN101186940B (zh) 2012-02-08
EP0906918B1 (de) 2002-05-15
DE19735711C2 (de) 2001-04-26
EP0906918A3 (de) 1999-08-11
ATE217636T1 (de) 2002-06-15
DE59803985D1 (de) 2002-06-06
HU9801886D0 (en) 1998-10-28
US5986048A (en) 1999-11-16
TR199801587A3 (tr) 1999-03-22
JPH11130798A (ja) 1999-05-18
DK0980874T3 (da) 2002-08-19
US20020156234A1 (en) 2002-10-24
HU228161B1 (en) 2013-01-28
EP0906918A2 (de) 1999-04-07
HK1119449A1 (en) 2009-03-06
HUP9801886A2 (hu) 1999-01-28
ES2177178T3 (es) 2002-12-01
HK1061870A1 (en) 2004-10-08
CA2245151C (en) 2009-10-06
CA2245151A1 (en) 1999-02-18
HUP9801886A3 (en) 1999-06-28
RU2205836C2 (ru) 2003-06-10
HK1018464A1 (en) 1999-12-24
ES2176870T3 (es) 2002-12-01
CN1483831B (zh) 2012-06-13
PT906918E (pt) 2002-10-31
US6727346B2 (en) 2004-04-27
HU228203B1 (en) 2013-01-28
HU0600287D0 (en) 2006-05-29
KR100537842B1 (ko) 2006-03-23
CN1132845C (zh) 2003-12-31
EP0980874B1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
TR199801587A2 (xx) �ns�lin �nc� molek�llerinin elde edilmesine y�nelik y�ntem.
TR200000740T2 (tr) Dişleri beyazlatmak için metod ve kompozisyonlar.
ID24377A (id) Senyawa hidrogen anorganik, metoda pemisahan dan penerapannya untuk bahan bakar
ATE338546T1 (de) Effektoren von dipeptidylpeptidase iv
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
AU2003245190A1 (en) Spacer preferably made entirely of ceramic and with an adapter
DE69819811D1 (de) Verbrennungsverfahren mit zweifacher Oxidationsmitteleinfuhr
IT1286348B1 (it) Amplificatore di potenza lineare con polarizzazione attiva ad alto rendimento e relativo metodo di amplificazione.
TR200102342T2 (tr) Paramilon içeren dondurularak kurutulmuş madde, bunun üretimi ve kullanımı.
ID28595A (id) Bahan pembawa termodifikasi, katalisoksida kompleks dan proses pembuatan asam akrilat
WO2000003445A3 (en) Electrode made of flexible graphite composite
TR200602113A2 (tr) Dağıtılmış azo boya karışımları.
TR200600582A1 (tr) N-(4-tiriflormetilfenil)-5-metil-[zoksazol-4-karboksamidin kristal formu
TR199801695A3 (tr) Akrilonitril ve hidrojen siyanürün imalati için gelistirilmis katalizör.
WO2001064834A8 (en) Novel nucleic acids and polypeptides
DE69808756D1 (de) Gasturbinenanlage mit mehrstufiger, partieller verbrennung
BR0115418A (pt) Processo
TR200501541T2 (tr) Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları
DE60219337D1 (de) Gewebe
ATE264340T1 (de) Stabilisierung von gefriergetrocknetem kuchen
TR199800302A2 (xx) Bunakl�kta kullan�ma y�nelik kombinasyon preparat�.
WO2004079517A3 (en) System and method for using a split-directory structure for software development
TR200001227T2 (tr) Yakıt bileşimi ve karışımı.
DK0868397T3 (da) Stabiliserede hydroxylaminopløsninger
WO2001000799A8 (fr) Nouvelle proteine et son adn